ZAVAMET 50/500

About

ZAVAMET 50/500 is a combination oral antidiabetic medication containing vildagliptin and metformin. Vildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that works by increasing the levels of incretin hormones, which in turn enhance insulin secretion and suppress glucagon release in a glucose-dependent manner. Metformin, a biguanide, primarily reduces hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity by increasing peripheral glucose uptake and utilization. This dual mechanism of action provides comprehensive glycemic control for patients with type 2 diabetes.

This medication is designed to improve blood sugar control in adults with type 2 diabetes mellitus when diet and exercise alone are not sufficient. The combination therapy offers synergistic effects, addressing multiple pathophysiological defects of type 2 diabetes, leading to more effective and sustained reductions in HbA1c levels compared to monotherapy. It is an important tool in managing hyperglycemia and preventing long-term complications associated with diabetes.

Uses

• Management of type 2 diabetes mellitus.
• As an adjunct to diet and exercise.
• When monotherapy with metformin or vildagliptin is insufficient.
• To improve glycemic control in adults.

Directions For Use

Take ZAVAMET 50/500 orally, usually twice daily with meals, or as directed by your healthcare provider. Swallow tablets whole; do not crush or chew.

Benefits

• Effective reduction in HbA1c levels.
• Dual mechanism of action for comprehensive glucose control.
• Improved insulin sensitivity and secretion.
• Generally well-tolerated with a low risk of hypoglycemia.
• Convenience of a single tablet combination.
• Supports weight management (metformin component).

Side Effects

• Nausea
• Diarrhea
• Abdominal pain
• Headache
• Dizziness
• Nasopharyngitis
• Tremor
• Fatigue
• Hypoglycemia (especially with other antidiabetics)
• Lactic acidosis (rare, serious)
• Pancreatitis (rare)
• Joint pain

Safety Measures

• Alcohol - Avoid excessive alcohol intake as it can increase the risk of lactic acidosis, a rare but serious side effect of metformin.
• Pregnancy - Generally not recommended during pregnancy. Consult your doctor to discuss risks and alternative treatments.
• Breastfeeding - Not advised during breastfeeding as components may pass into breast milk. Seek medical advice.
• Liver - Use with caution in patients with liver impairment. Metformin is contraindicated in severe hepatic dysfunction due to increased risk of lactic acidosis.
• Kidney - Dose adjustment is required based on kidney function (eGFR). Contraindicated in severe renal impairment due to metformin accumulation.
• Lung - Use with caution in patients with severe respiratory conditions that may predispose to hypoxia and increase the risk of lactic acidosis.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.